Cadrenal Therapeutics, Inc. (CVKD) › Cost of RevenueCadrenal Therapeutics, Inc. (CVKD) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2008: $220.1K2023: $220.1K$220.1K2008Cost of Revenue (USD)2023Fiscal YearCost of RevenueChange YoY2023$220.1K—2008$220.1K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share